1. RABBIT risk score and ICU admission due to infection in patients with rheumatoid arthritis
- Author
-
Franz Gruber, Clemens Steinwender, Lorenz Auer-Hackenberg, Herwig Pieringer, Erich Pohanka, Rainer Hintenberger, and Jens Meier
- Subjects
Male ,medicine.medical_specialty ,Infections ,law.invention ,Arthritis, Rheumatoid ,03 medical and health sciences ,0302 clinical medicine ,Rheumatology ,law ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Glucocorticoids ,Aged ,030203 arthritis & rheumatology ,Biological Products ,COPD ,Framingham Risk Score ,business.industry ,General Medicine ,Middle Aged ,medicine.disease ,Intensive care unit ,Surgery ,Icu admission ,Hospitalization ,Intensive Care Units ,Antirheumatic Agents ,Case-Control Studies ,Rheumatoid arthritis ,Female ,business ,Glucocorticoid ,medicine.drug ,Kidney disease - Abstract
Rheumatoid arthritis (RA) patients are at increased risk of infection. Aim of the present study was to investigate whether RA patients admitted to an intensive care unit (ICU) due to infection have higher Rheumatoid Arthritis Observation of Biologic Therapy (RABBIT) risk scores compared to control RA patients. Seventy-four RA patients (32.4% male) admitted to an ICU due to infection (from January 2002 to December 2013) and 74 frequency-matched control RA patients (16.2% male) were included in this cross-sectional study. There was strong evidence for a higher RABBIT risk score in ICU patients (median 2.0; IQR 1.3–3.2) as compared to controls (1.3; IQR 0.8–2.0; p
- Published
- 2017
- Full Text
- View/download PDF